Related Experiment Video
Updated: Jun 3, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma
Igor Matushansky1, Robert N Taub
1Division Of Medical Oncology, Department of Medicine, Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, 177 Fort Washington Avenue, Milstein Hospital Building 6-435, New York, NY 10032, USA. im17@columbia.edu
Nature Reviews. Clinical Oncology
|March 23, 2011
Summary
Adjuvant chemotherapy is not a standard treatment for adult soft-tissue sarcomas due to complex subtypes and rarity. Research continues to evaluate its effectiveness in preventing distant metastases after surgery.
Area of Science:
- Medical Oncology
- Surgical Oncology
- Clinical Research
Background:
- Wide surgical excision is the primary treatment for adult soft-tissue sarcomas.
- High-grade sarcomas frequently metastasize distantly despite adequate local control, leading to poor outcomes.
- A 30-year research effort has focused on adjuvant therapy efficacy for these rare and diverse tumors.
Approach:
- This perspectives article reviews existing data on adjuvant chemotherapy for soft-tissue sarcomas.
- The analysis considers the challenges posed by numerous histopathological subtypes and tumor rarity.
- Evidence supporting or refuting adjuvant chemotherapy use is critically examined.
Key Points:
- Histopathological diversity and rarity complicate the assessment of adjuvant therapy effectiveness.
- Distant metastases remain a significant challenge for patients with high-grade soft-tissue sarcomas.
- The role of adjuvant chemotherapy in improving outcomes is still under investigation.
Conclusions:
- The efficacy of adjuvant chemotherapy for adult soft-tissue sarcomas remains uncertain.
- Further research is needed to clarify the role of adjuvant therapy in managing these complex cancers.
- Treatment decisions require careful consideration of tumor characteristics and available evidence.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...